Nucleai

nucleai.ai

Nucleai is committed to transforming patient care through AI-driven spatial biomarkers and diagnostics, leveraging advanced geospatial AI methods to analyze complex cellular interactions in biopsies. Their technology is the first spatial AI tool used by pathologists for clinical trial patient selection, directly linked to drug development programs. Nucleai's platform offers a multimodal solution for biomarker discovery, scoring, and genomic screening, aiming to optimize treatment decisions and accelerate the development of life-saving therapeutics. With a focus on precision medicine, Nucleai is positioned at the forefront of the biopharma industry, enhancing drug development processes and improving patient outcomes.